Abstract
A medullary thyroid cancer (MTC)/multiple endocrine neoplasia syndrome was suspected in a patient having an metaiodobenzylguanidine (MIBG) scan while she was being investigated for pheochromocytoma. After surgery, this was confirmed histologically. Although MIBG scanning cannot be used as a screening tool for MTC because of its poor sensitivity for detection of MTC, this case report highlights that one should always scrutinize the thyroid gland while interpreting MIBG scans.
Original language | English |
---|---|
Pages (from-to) | 328-329 |
Number of pages | 2 |
Journal | Clinical Nuclear Medicine |
Volume | 33 |
Issue number | 5 |
DOIs | |
Publication status | Published - May 2008 |
Externally published | Yes |
Fingerprint
Keywords
- Medullary thyroid cancer
- Metaiodobenzylguanidine (MIBG)
- Multiple endocrine neoplasia
- Phaeochromocytoma
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
- Radiological and Ultrasound Technology
Cite this
Detection of medullary thyroid cancer with MIBG imaging for pheochromocytoma. / Newton, Tom Douglas; Augustine, Titus; Arumugam, Parthiban; Malik, Rayaz.
In: Clinical Nuclear Medicine, Vol. 33, No. 5, 05.2008, p. 328-329.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Detection of medullary thyroid cancer with MIBG imaging for pheochromocytoma
AU - Newton, Tom Douglas
AU - Augustine, Titus
AU - Arumugam, Parthiban
AU - Malik, Rayaz
PY - 2008/5
Y1 - 2008/5
N2 - A medullary thyroid cancer (MTC)/multiple endocrine neoplasia syndrome was suspected in a patient having an metaiodobenzylguanidine (MIBG) scan while she was being investigated for pheochromocytoma. After surgery, this was confirmed histologically. Although MIBG scanning cannot be used as a screening tool for MTC because of its poor sensitivity for detection of MTC, this case report highlights that one should always scrutinize the thyroid gland while interpreting MIBG scans.
AB - A medullary thyroid cancer (MTC)/multiple endocrine neoplasia syndrome was suspected in a patient having an metaiodobenzylguanidine (MIBG) scan while she was being investigated for pheochromocytoma. After surgery, this was confirmed histologically. Although MIBG scanning cannot be used as a screening tool for MTC because of its poor sensitivity for detection of MTC, this case report highlights that one should always scrutinize the thyroid gland while interpreting MIBG scans.
KW - Medullary thyroid cancer
KW - Metaiodobenzylguanidine (MIBG)
KW - Multiple endocrine neoplasia
KW - Phaeochromocytoma
UR - http://www.scopus.com/inward/record.url?scp=42549157082&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=42549157082&partnerID=8YFLogxK
U2 - 10.1097/RLU.0b013e31816a7a4d
DO - 10.1097/RLU.0b013e31816a7a4d
M3 - Article
C2 - 18431145
AN - SCOPUS:42549157082
VL - 33
SP - 328
EP - 329
JO - Clinical Nuclear Medicine
JF - Clinical Nuclear Medicine
SN - 0363-9762
IS - 5
ER -